During the past decade, Southern Tohoku Medical Clinic conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southern Tohoku Medical Clinic" #1 collaborator was "Teijin Pharma Limited" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Southern Tohoku Medical Clinic" are "Alzheimer Disease" (2 trials), "Central Neuropathic Pain" (1 trials), "Heart Failure" (1 trials) and "Hyperuricemia" (1 trials). Many other conditions were trialed in "Southern Tohoku Medical Clinic" in a lesser frequency.

Most popular intervention types in "Southern Tohoku Medical Clinic" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Gantenerumab" (2 trials), "Eplerenone" (1 trials), "Febuxostat" (1 trials) and "Mirogabalin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Southern Tohoku Medical Clinic" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Southern Tohoku Medical Clinic". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Southern Tohoku Medical Clinic, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Southern Tohoku Medical Clinic, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".